Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries.

Ida PesonenLisa CarlsonNicola MurgiaRiitta KaarteenahoCarl Magnus SköldMarjukka MyllärniemiGiovanni Ferrara

Published in: Multidisciplinary respiratory medicine (2018)

This study highlights differences concerning how IPF patients are treated in Finland and Sweden. How these differences will influence the long-term outcome of these patients is unknown.

Keyphrases

idiopathic pulmonary fibrosis
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes
interstitial lung disease
combination therapy